SCHEMBL30880033

SCHEMBL30880033

COC(=O)c1c[nH]c(C(=O)c2ccc(Br)cc2)c1-c1c(F)ccc(F)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 7/20 0.41
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ LMNA P02545 3/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.34
▸ MAP2K1 Q02750 1/20 0.34
▸ CREBBP Q92793 1/20 0.33
▸ HPGD P15428 2/20 0.33
▸ F2 P00734 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30880032 1.00 NR4A2 (0.41) NR4A2MAPTALDH1A1RAB9AKDM4E
SCHEMBL30880042 0.89 SMN1; SMN2 (0.42) NR4A2MAPTALDH1A1RAB9AKDM4E
SCHEMBL30880013 0.88 NR4A2 (0.40) NR4A2ALDH1A1LMNAKMT2AMEN1
SCHEMBL35211913 0.82 CYP4A11 (0.35) NR4A2CREBBPNPC1
SCHEMBL35211910 0.82 CYP4A11 (0.35) NR4A2CREBBPNPC1
SCHEMBL35211571 0.82 CYP4A11 (0.35) NR4A2CREBBPNPC1
SCHEMBL31342430 0.79 CYP4A11 (0.39) NR4A2NPC1
SCHEMBL35212509 0.79 AR (0.34) MAPTALDH1A1KDM4ELMNAKMT2A
SCHEMBL35212228 0.79 AR (0.34) MAPTALDH1A1KDM4ELMNAKMT2A
SCHEMBL30937357 0.78 PRKAB2 (0.44) MAPTALDH1A1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090412-A1 DCAF1 LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2025-05-01 — — WO disclosed
WO-2024092011-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-05-02 — — WO disclosed
Send feedback